{
  "company": {
    "name": "Alesta Therapeutics",
    "website": "https://alestatherapeutics.com/",
    "record": "https://startuphistory.org/c/alestatherapeutics.com"
  },
  "status": null,
  "history_since": "2025-07-16T08:07:35.000Z",
  "baseline": {
    "snapshot_id": "e321884de82f63d969fe291e3093f7401c5f26d6dddeedb4fbdcafffb45db7b9",
    "observed_at": "2025-07-16T08:07:35.000Z",
    "headline": "PIONEERING SMALL MOLECULE THERAPEUTICS",
    "description": "Alesta Therapeutics is advancing precision small molecule therapies for rare genetic diseases like hypophosphatasia (HPP) and Charcot-Marie-Tooth disease (CMT)",
    "evidence": "https://web.archive.org/web/20250716080735/https://alestatherapeutics.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [
            "Droia Ventures",
            "SSI Strategy",
            "RTW",
            "Novartis Venture Fund",
            "RV Invest",
            "Frazier Life Sciences"
          ],
          "prices": [],
          "compliance": [],
          "funding": []
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T14:19:16.470Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-10-10T14:41:22.000Z",
      "variants": [
        {
          "headline": "PIONEERING SMALL MOLECULE THERAPEUTICS",
          "subhead": "Alesta Therapeutics is advancing precision small molecule therapies for rare genetic diseases like hypophosphatasia (HPP) and Charcot-Marie-Tooth disease (CMT)",
          "observed_at": "2025-07-16T08:07:35.000Z",
          "evidence": "https://web.archive.org/web/20250716080735/https://alestatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "PIONEERING SMALL MOLECULE THERAPEUTICS",
          "subhead": "Alesta Therapeutics is advancing precision small molecule therapies for rare genetic diseases like hypophosphatasia (HPP) and Charcot-Marie-Tooth disease (CMT)",
          "observed_at": "2025-10-10T14:41:22.000Z",
          "evidence": "https://web.archive.org/web/20251010144122/https://alestatherapeutics.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "PIONEERING SMALL MOLECULE THERAPEUTICS",
      "subhead": "Alesta Therapeutics is advancing precision small molecule therapies for rare genetic diseases like hypophosphatasia (HPP) and Charcot-Marie-Tooth disease (CMT)",
      "from": "2025-07-16T08:07:35.000Z",
      "to": "2025-10-10T14:41:22.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20251010144122/https://alestatherapeutics.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2025-07-16T08:07:35.000Z",
          "to": "2025-10-10T14:41:22.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T14:19:16.470Z",
      "variants": [
        {
          "headline": "Small molecules, life-changing power.",
          "subhead": "Alesta Therapeutics is a biotech company developing novel oral small molecule therapies for underserved rare diseases.",
          "observed_at": "2026-04-23T02:20:52.000Z",
          "evidence": "https://web.archive.org/web/20260423022052/https://www.alestatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Small molecules, life-changing power.",
          "subhead": "Alesta Therapeutics is a biotech company developing novel oral small molecule therapies for underserved rare diseases.",
          "observed_at": "2026-08-25T07:50:22.000Z",
          "evidence": "https://web.archive.org/web/20260825075022/https://www.alestatherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Small molecules, life-changing power.",
          "subhead": "Alesta Therapeutics is a biotech company developing novel oral small molecule therapies for underserved rare diseases.",
          "observed_at": "2026-11-06T14:19:16.470Z",
          "evidence": "https://www.alestatherapeutics.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Small molecules, life-changing power.",
      "subhead": "Alesta Therapeutics is a biotech company developing novel oral small molecule therapies for underserved rare diseases.",
      "from": "2026-04-23T02:20:52.000Z",
      "to": "2026-11-06T14:19:16.470Z",
      "captures": 3,
      "evidence": "https://www.alestatherapeutics.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-04-23T02:20:52.000Z",
          "to": "2026-11-06T14:19:16.470Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-202ab0ef237e48c6f1224087992325e04b1338b73699a93498b616ef4a275a3d:4743bf9b422f6c9ccbc141a178e982be61307c6a32f0db28fa2473b00fba97e2:headline:7e446deeb425f9c4",
      "before_evidence": "https://web.archive.org/web/20251010144122/https://alestatherapeutics.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “PIONEERING SMALL MOLECULE THERAPEUTICS” to “Small molecules, life-changing power.”.",
      "between": {
        "from": "2025-10-10T14:41:22.000Z",
        "to": "2026-04-23T02:20:52.000Z"
      },
      "evidence": "https://web.archive.org/web/20260423022052/https://www.alestatherapeutics.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-202ab0ef237e48c6f1224087992325e04b1338b73699a93498b616ef4a275a3d:4743bf9b422f6c9ccbc141a178e982be61307c6a32f0db28fa2473b00fba97e2:investors:b99fe1c398260524",
      "before_evidence": "https://web.archive.org/web/20251010144122/https://alestatherapeutics.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: Thuja Capital, Frazier and RTQ.",
      "between": {
        "from": "2025-10-10T14:41:22.000Z",
        "to": "2026-04-23T02:20:52.000Z"
      },
      "evidence": "https://web.archive.org/web/20260423022052/https://www.alestatherapeutics.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Alesta Therapeutics” company record, https://startuphistory.org/c/alestatherapeutics.com"
}